(Q38210423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

The application of nanosponges to cancer drug delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Fabrizio Caldera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Francesco Trotta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Barbara Mognetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Roberta Cavalli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

8 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

931-941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

Nanomedicine--challenge and perspectives

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Advances in nano drugs for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanoparticles in drug delivery: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanocapsules: A new type of lysosomotropic carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Small-molecule delivery by nanoparticles for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Size and shape effects in the biodistribution of intravascularly injected particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanotechnology for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Liposomal drug delivery systems: from concept to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Targeting nanoparticles to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cyclodextrin-based nanosponges as drug carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cyclodextrin-based nanogels for pharmaceutical and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanosponge formulations as oxygen delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

21 January 2018

Oral delivery of taxanes

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Preparation and characterization of solid lipid nanospheres containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Efficient oral delivery of paclitaxel using cyclodextrin complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Camptothecin delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Administration of resveratrol: What formulation solutions to bioavailability limitations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Stimuli-responsive polymers: biomedical applications and challenges for clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.911729

10.1517/17425247.2014.911729

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24811423%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference